North American Scientific, Inc.’s NOMOS Radiation Oncology division has introduced Batcam Multi-probe, its new IGRT solution, at the upcoming 49th Annual Meeting of the American Association of Physics in Medicine (AAPM). Batcam Multi-probe received FDA 510(k) approval on July 11, 2007. AAPM is being held this week in Minneapolis, Minn.
Batcam Multi-probe integrates a new multi-probe capable ultrasound system into the company's core IGRT product, Batcam. The new system features an updated abdominal ultrasound probe featuring color doppler ultrasound enabling IGRT for liver and pancreas treatments in addition to prostate and gynecology. Optional add-ons to the system include a bi-planar rectal probe for prostate volume studies and prostate brachytherapy, and a wideband, linear probe for verification of Accelerated Partial Breast Irradiation (APBI) brachytherapy devices such as ClearPath(TM). Batcam Multi-probe is expected to be available for shipment in early August.
"Batcam Multi-probe is a crucial advancement in providing improved imaging and value to clinicians seeking IGRT solutions and offers greater utility in addition to expanded clinical IGRT use," said John Rush, president and CEO of North American Scientific.